Skip to main content
. 2024 Feb 7;25(4):2009. doi: 10.3390/ijms25042009
PD Parkinson’s disease
SNc Substantia nigra pars compacta
DA Dopamine
NE Norepinephrine
LC Locus coeruleus
NM Neuromelanin
LB Lewy bodies
TH Tyrosine hydroxylase
CA Catecholamine
VTA Ventral tegmental area
Nac Nucleus accumbens
MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
OXPHOS Oxidative phosphorylation
ROS Reactive oxygen species
FDG Fluorodeoxyglucose
ATP Adenosine triphosphate
HHS Vulnerability Disclosure